Abstract |
Angiosarcoma is a rare neoplasm, accounting for only 1%-2% of all sarcomas. It occurs most frequently in the skin and soft tissue and rarely in the thoracic region. To our knowledge, a mediastinal angiosarcoma is extremely rare. We report on the surgical resection of a rare case of giant epithelioid angiosarcoma originating in the anterior mediastinum, followed by six courses of adjuvant chemotherapy ( doxorubicin + ifosfamide). The patient is alive and asymptomatic 1 year after surgery. As the prognosis for unresectable cases is generally dismal, surgical resection and adjuvant therapy can be an option for mediastinal angiosarcoma.
|
Authors | Shinya Tane, Yugo Tanaka, Syunsuke Tauchi, Kazuya Uchino, Reiko Nakai, Masahiro Yoshimura |
Journal | General thoracic and cardiovascular surgery
(Gen Thorac Cardiovasc Surg)
Vol. 59
Issue 7
Pg. 503-6
(Jul 2011)
ISSN: 1863-6713 [Electronic] Japan |
PMID | 21751114
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Biopsy
- Chemotherapy, Adjuvant
- Doxorubicin
(administration & dosage)
- Epithelioid Cells
(pathology)
- Hemangiosarcoma
(diagnosis, drug therapy, pathology, surgery)
- Humans
- Ifosfamide
(administration & dosage)
- Immunohistochemistry
- Male
- Mediastinal Neoplasms
(diagnosis, drug therapy, pathology, surgery)
- Neoplasm Invasiveness
- Positron-Emission Tomography
- Sternotomy
- Thoracic Surgical Procedures
- Tomography, X-Ray Computed
- Treatment Outcome
- Vascular Surgical Procedures
|